KG&L Capital Management LLC Sells 1,244 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

KG&L Capital Management LLC lessened its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 41.5% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,751 shares of the healthcare conglomerate’s stock after selling 1,244 shares during the quarter. KG&L Capital Management LLC’s holdings in UnitedHealth Group were worth $1,024,000 as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in UNH. Robeco Institutional Asset Management B.V. grew its holdings in UnitedHealth Group by 28.8% during the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 674,466 shares of the healthcare conglomerate’s stock valued at $394,347,000 after purchasing an additional 150,716 shares during the last quarter. Blue Square Asset Management LLC lifted its position in UnitedHealth Group by 4.1% during the third quarter. Blue Square Asset Management LLC now owns 5,118 shares of the healthcare conglomerate’s stock valued at $2,992,000 after acquiring an additional 203 shares during the last quarter. Lansing Street Advisors increased its position in UnitedHealth Group by 3.4% during the 3rd quarter. Lansing Street Advisors now owns 739 shares of the healthcare conglomerate’s stock valued at $432,000 after buying an additional 24 shares in the last quarter. BSW Wealth Partners raised its position in shares of UnitedHealth Group by 20.5% in the 3rd quarter. BSW Wealth Partners now owns 2,457 shares of the healthcare conglomerate’s stock valued at $1,436,000 after purchasing an additional 418 shares during the last quarter. Finally, Angeles Wealth Management LLC grew its holdings in shares of UnitedHealth Group by 4.0% during the third quarter. Angeles Wealth Management LLC now owns 2,711 shares of the healthcare conglomerate’s stock valued at $1,585,000 after buying an additional 105 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Up 0.5 %

UNH stock opened at $567.56 on Monday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.88 and a current ratio of 0.91. The stock has a market capitalization of $524.10 billion, a PE ratio of 36.97, a price-to-earnings-growth ratio of 1.66 and a beta of 0.58. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $608.63. The company has a fifty day moving average of $581.96 and a 200-day moving average of $542.45.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm’s revenue was up 9.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $6.56 earnings per share. As a group, analysts expect that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were paid a dividend of $2.10 per share. The ex-dividend date was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.48%. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on UNH. Truist Financial reiterated a “buy” rating and issued a $625.00 price objective (down previously from $640.00) on shares of UnitedHealth Group in a research note on Wednesday, October 16th. Argus boosted their target price on UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. UBS Group dropped their price target on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. TD Cowen raised their price objective on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. Finally, Barclays reduced their price target on shares of UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 22nd. Four research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus target price of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.